DUK-CPG-001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DUK-CPG-001, covering 2024-02-20 to 2024-02-20. Get the full timeline:
Most recent: Clinical Trial Update: Ph2 NK Cell Enriched DCIs w/wo RLR9 Agonist, DUK-CPG-001 From Donors Following Allogeneic SCT [Phase 2]